amlodipine has been researched along with Hypoplastic Left Heart Syndrome in 1 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Hypoplastic Left Heart Syndrome: A condition caused by underdevelopment of the whole left half of the heart. It is characterized by hypoplasia of the left cardiac chambers (HEART ATRIUM; HEART VENTRICLE), the AORTA, the AORTIC VALVE, and the MITRAL VALVE. Severe symptoms appear in early infancy when DUCTUS ARTERIOSUS closes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamzeh, R | 1 |
| Bulbul, Z | 1 |
| Assy, J | 1 |
1 other study available for amlodipine and Hypoplastic Left Heart Syndrome
| Article | Year |
|---|---|
Successful use of calcium channel blocker for management of arterio-venous malformations following Fontan procedure.
Topics: Amlodipine; Arteriovenous Malformations; Calcium Channel Blockers; Child, Preschool; Female; Fontan | 2018 |